Extracorporeal organ support (ECOS) plays a crucial role in rescuing critically ill patients, however, there are adverse events such as bleeding and thrombosis during treatment, so selecting appropriate anticoagulants is very important in ECOS therapy. This article reviewed the anticoagulant application of heparin, low molecular weight heparin, direct thrombin inhibitors, and citric acid in extracorporeal membrane oxygenation (ECMO) and continuous renal replacement therapy (CRRT), elucidated the current usage status of anticoagulant drugs in ECMO and CRRT, summarized their characteristics, contraindications and associated adverse reactions, in order to provide certain theoretical basis for deeply exploring alternative options to heparin in ECMO and selecting appropriate anticoagulant drugs for high-risk bleeding patients undergoing CRRT.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |